Do you want to read an article? Please log in or register.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Thrombosis and Stroke
Related content
RECOMMENDED
Thrombosis and Stroke
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
N Engl J Med.
Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K, RE-SPECT ESUS Steering Committee and Investigators.
doi: 10.1056/NEJMoa1813959.
Atrial FibrillationThrombosis and StrokeTherapy and Intervention
Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation
Eur Heart J Suppl.
Antoniou S, Amara W
doi: 10.1093/eurheartj/suv061.
Thrombosis and Stroke
Association Between Left Ventricular Ejection Fraction, Wall Motion Abnormality, and Embolic Stroke of Undetermined Source
J Am Heart Assoc.
Ramasamy S, Yaghi S, Salehi Omran S, Lerario MP, Devereux R, Okin PM, Gupta A, Navi BB, Kamel H, Merkler AE
doi: 10.1161/JAHA.
Atrial FibrillationThrombosis and Stroke
Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort
Circ Cardiovasc Qual Outcomes.
Bonde AN, Martinussen T, Lee CJ, Lip GYH, Staerk L, Bang CN, Bhattacharya J, Gislason G, Torp-Pedersen C, Olesen JB, Hlatky MA
doi: 10.1161/CIRCOUTCOMES.
Atrial Fibrillation
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial
JAMA Neurol.
Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ, Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG, Connolly SJ
doi: 10.1001/
Thrombosis and Stroke
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis
Lancet Haematol.
Dawwas GK, Brown J, Dietrich E, Park H
doi: 10.1016/S2352-
Atrial FibrillationHeart FailureHypertensionThrombosis and Stroke
Global Prospective Safety Analysis of Rivaroxaban
J Am Coll Cardiol.
Kirchhof P, Radaideh G, Kim YH, Lanas F, Haas S, Amarenco P, Turpie AGG, Bach M, Lambelet M, Hess S, Camm AJ; Global XANTUS program Investigators
doi: 10.1016/j.jacc.2018.04.058.
COMMENTED
Thrombosis and Stroke
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
Stroke
Bosch J, Lonn EM, Dagenais GR, Gao P, Lopez-Jaramillo P, Zhu J, Pais P, Avezum A, Sliwa K, Chazova IE, Peters RJG, Held C, Yusoff K, Lewis BS, Toff WD, Khunti K, Reid CM, Leiter LA, Yusuf S, Hart RG, HOPE-3 Investigators.
doi: 10.1161/STROKEAHA.120.030790
Thrombosis and Stroke
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL; American Heart Association Stroke Council
doi: 10.1161/